Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present ProShares Trust (NASDAQ: ZBIO).

Full DD Report for ZBIO

You must become a subscriber to view this report.


Recent News from (NASDAQ: ZBIO)

ProShares announces ETF share splits
ProShares announced splits on ETF: More news on: ProShares Ultra MidCap 400 ETF, ProShares Ultra Financials ETF, ProShares Ultra Dow 30 ETF, News on ETFs, Read more ...
Source: SeekingAlpha
Date: May, 10 2018 13:28
ProShares announces splits, reverse splits on 20 ETFs
The following are forward splitting shares 3-for-1 after the close on May 23: ProShares Ultra S&P MidCap400 (NYSEARCA: MVV ), ProShares Ultra Financials (NYSEARCA: UYG ), ProShares Ultra Dow30 (NYSEARCA: DDM ), ProShares Ultra MSCI EAFE (NYSEARCA: EFO ), ProShare...
Source: SeekingAlpha
Date: May, 09 2018 16:43
ProShares Announces ETF Share Splits
ProShares, a premier provider of ETFs, announced today forward and reverse share splits on 20 of its ETFs. The splits will not change the total value of a shareholder's investment. Forward Splits Eight ETFs will forward split shares 3-for-1: All forward splits will apply to sha...
Source: Business Wire
Date: May, 09 2018 16:33
ETF Deathwatch For March 2018
By Jason Teed ETF Deathwatch for March had 14 closures and 18 exits. Eighteen of the funds left the Deathwatch list due to improved health, mainly resulting from an increase in assets under management (AUM). Fourteen were closed by their parent companies. March also saw 22 additions to the...
Source: SeekingAlpha
Date: April, 13 2018 16:25
Seeking Out Innovators In Cancer Therapy
By Andy Acker & Daniel Lyons, Ph.D., CFA See how Global Life Sciences Portfolio Manager Andy Acker and Research Analyst Dan Lyons analyze biotechnology companies pursuing innovative platforms and research to bring new therapies to patients with major unmet medical needs, such as cancer...
Source: SeekingAlpha
Date: April, 10 2018 05:36
The Bio-Tech 'Wreck': General, And Company-Specific Analysis
Introduction - if no bad luck, then no luck at all? Has biotech really been born under a bad sign ? Some days/weeks/months/years it really appears so, with the Incyte ( INCY ) blow-up the latest example (see below for brief discussion). There is no clear definition these days of what ...
Source: SeekingAlpha
Date: April, 09 2018 09:43
The Key To Investing In Biotechs: Forget About The Broader Market And Focus On The Catalysts
February was a dicey month for biotech stocks. Fears of inflation and rising interest rates sent stocks down across the board , erasing the gains of 2018, but small developmental biotechs took it harder. That is unsurprising, given that these companies represent high-risk, high reward opportu...
Source: SeekingAlpha
Date: March, 22 2018 06:49
Healthcare Costs: USA Vs. The Rest Of The World Part 2
In part 1 of our healthcare special, analyst Ben Nye and social media intern Chris Annunzio discussed the recent JAMA (Journal of the American Medical Association) report which focused on the high costs of healthcare in the United States. The report collected data from 10 other high-income...
Source: SeekingAlpha
Date: March, 21 2018 09:40
Healthcare Costs: USA Vs. The Rest Of The World | Part 1
Healthcare in the United States is portrayed to be top-notch and part of this reputation is a result of the population paying high prices for quick and efficient care. In a recent report published by JAMA (Journal of the American Medical Association) , ten other high-income countries are exam...
Source: SeekingAlpha
Date: March, 20 2018 09:48
Deflation Coming In Healthcare
*This is an abridged post from my [Weekly Macro Theme] report shared to members of EPB Macro Research . To see the full report and learn how to join EPB Macro Research for free, click here .* Deflation In Healthcare ( XLV ) For the better part of the past five years, the healthcare s...
Source: SeekingAlpha
Date: February, 20 2018 13:02

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-05-179.7869.779.9319.7723,959
2017-03-1015.7816.0416.0915.7510,911
2017-03-0916.3216.1116.5015.922419,382
2017-03-0816.8016.2016.8015.824391,787
2017-03-0716.4916.6916.8616.3061,517

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-08-212,1962,74180.1167Short
2018-08-201,2072,50748.1452Short
2018-08-1731461451.1401Short
2018-08-167571,58747.7001Short
2018-08-155,1876,52879.4577Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on ZBIO.


About ProShares Trust (NASDAQ: ZBIO)

Logo for ProShares Trust (NASDAQ: ZBIO)

Not available

 

Contact Information

 

 

Current Share Structure

     



    Daily Technical Chart for (NASDAQ: ZBIO)

    Daily Technical Chart for (NASDAQ: ZBIO)


    Stay tuned for daily updates and more on (NASDAQ: ZBIO)

    It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

    More to come on (NASDAQ: ZBIO)

    Do your DD and if you choose, be ready to go!


     

    The Research: All source information contained in this email is from the public sources mentioned below.

     

     
     

    Thank you

    DD Report
    @DDReports

     

     


    Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in ZBIO is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. DD Report does not own any shares of ZBIO and does not buy, sell, or trade any shares of ZBIO. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: http://dd.report/disclaimer/